Skip to Main Content

951

Views

34

CrossRef citations to date

0

Altmetric

Review

Combination therapy with oncolytic viruses and immune checkpoint inhibitors

Matthew ChiuDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK;The Royal Marsden NHS Foundation Trust, London, UKView further author information

,

Edward John Lloyd ArmstrongDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK;The Royal Marsden NHS Foundation Trust, London, UKView further author information

,

Vicki JenningsDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

Shane FooDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

Eva Crespo-RodriguezDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

Galabina BozhanovaDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

Emmanuel Christian PatinDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

Martin McLaughlinDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

David MansfieldDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

Gabriella BakerDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

Lorna GroveDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

Malin PedersenDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

Joan KyulaDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

Victoria RoulstoneDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKView further author information

,

Anna WilkinsTumour Cell Biology Laboratory, The Francis Crick Institute, London, UKView further author information

,

Fiona McDonaldThe Royal Marsden NHS Foundation Trust, London, UKView further author information

,

Kevin HarringtonDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK;The Royal Marsden NHS Foundation Trust, London, UKView further author information

&

Alan MelcherDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK;The Royal Marsden NHS Foundation Trust, London, UKCorrespondence[email protected]
View further author information